Smith & Nephew plc has announced the appointment of Julie Brown as Chief Financial Officer. She will formally take up the post by early February 2013, when she will also be appointed to the Board as an Executive Director.
Julie joins from AstraZeneca PLC, where she served as Vice President Group Finance and recently as Interim Chief Financial Officer. In her 25 years with AstraZeneca (and predecessor companies) she has held a number of senior financial and management positions including Regional Vice President Latin America, Marketing Company President AZ Portugal and Vice President Corporate Strategy and Research and Development Chief Financial Officer.
She qualified as a Chartered Accountant with KPMG and is a Fellow of the Institute of Chartered Accountancy and a Fellow of the Institute of Taxation. Julie is a British national.
Olivier Bohuon, Chief Executive Smith & Nephew, commented: “Julie is an outstanding leader who brings to Smith & Nephew exceptional financial expertise and a deep knowledge of the healthcare market. Her ability to build teams and her broad experience working across geographies and within senior commercial roles will undoubtedly enable her to be a strong business partner. I look forward to working closely together as we continue to reshape Smith & Nephew for future success.”
New CFO comments
Julie Brown commented: “I am excited to be joining Smith & Nephew with the Company at such an important point in its development, and I am looking forward to working alongside Olivier and the entire Smith & Nephew team.”
Source: Smith & Nephew plc